Regulatory News In Brief
NAD finds Nitraflex “strength” claim weak; FDA nixes BPA coating in infant formula packaging; Herbs of Light in the dark on GMPs, claims; AHPA floats softer Prop 65 warnings; and U.K. aims to end unlicensed herbal sales.
NAD finds Nitraflex “strength” claim weak; FDA nixes BPA coating in infant formula packaging; Herbs of Light in the dark on GMPs, claims; AHPA floats softer Prop 65 warnings; and U.K. aims to end unlicensed herbal sales.